Telix Pharmaceuticals Limited (ASX:TLX)

Telix Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021
Net Income	-7.13	33.69	4.21	-70.74	-58.54
Depreciation & Amortization	20.95	5.28	4.16	3.66	3.76
Other Amortization	0.46	-	-	-	-
Asset Writedown & Restructuring Costs	0.57	-0.48	0.55	-	-
Stock-Based Compensation	19.35	12.93	5.85	5.51	0.96
Other Operating Activities	-6.28	19.08	24.03	18.77	12.59
Change in Accounts Receivable	-20.47	-37.49	-18.62	-13.55	-5.23
Change in Inventory	-7.64	-2.13	-6.55	-3.41	-2.05
Change in Accounts Payable	28.98	28.84	18.09	20.7	5.44
Change in Unearned Revenue	-9.13	-6.23	-3.43	-1.91	-1.96
Change in Other Net Operating Assets	-36.96	-26.01	-14	-2.51	1.89
Operating Cash Flow	-17.29	27.49	14.27	-43.48	-43.14
Operating Cash Flow Growth	-	92.60%	-	-	-
Capital Expenditures	-25.69	-9.12	-6.31	-4.78	-0.97
Cash Acquisitions	-229.03	-23.2	-1	-0.66	-
Sale (Purchase) of Intangibles	-18.08	-13.07	-0.8	-4.64	-
Investment in Securities	-0.89	-32.91	-8.7	-	-
Other Investing Activities	-12.22	-8.4	-0.04	-1.47	-1.01
Investing Cash Flow	-285.92	-86.69	-16.84	-11.55	-1.98
Long-Term Debt Issued	0.53	427.9	4.19	2.05	-
Long-Term Debt Repaid	-6.06	-2.06	-1.27	-0.87	-0.68
Net Debt Issued (Repaid)	-5.53	425.84	2.92	1.18	-0.68
Issuance of Common Stock	1.81	0.66	4.17	123.05	2.75
Other Financing Activities	-	-9.71	-	-5.31	-
Financing Cash Flow	-3.72	416.79	7.09	118.92	2.07
Foreign Exchange Rate Adjustments	8.8	-1.89	0.99	0.2	2.4
Net Cash Flow	-298.13	355.7	5.52	64.09	-40.65
Free Cash Flow	-42.99	18.37	7.97	-48.26	-44.11
Free Cash Flow Growth	-	130.64%	-	-	-
Free Cash Flow Margin	-5.35%	3.56%	2.39%	-44.35%	-798.67%
Free Cash Flow Per Share	-0.13	0.05	0.03	-0.15	-0.16
Cash Interest Paid	13.7	3.09	0.39	0.28	0.14
Cash Income Tax Paid	21.3	2.03	6.86	-11.3	-8.81
Levered Free Cash Flow	-36.67	53.71	41.26	-20.88	-27.18
Unlevered Free Cash Flow	-28.07	56.71	41.58	-20.74	-27.11
Change in Working Capital	-45.22	-43.01	-24.51	-0.68	-1.91

Source: S&P Global Market Intelligence. Standard template. Financial Sources.